Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

To examine the effects of intranasal insulin administration on cognition, function, cerebral glucose metabolism, and cerebrospinal fluid biomarkers in adults with amnestic mild cognitive impairment or Alzheimer disease (AD).

Randomized, double-blind, placebo-controlled trial.